Trial Profile
A Multicenter, Randomized, Double-Blind, 12-Week Study Of The Safety And Efficacy Of AN2728 Versus AN2728 Vehicle In The Treatment Of Patients With Mild-To-Moderate Plaque-Type Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Anacor Pharmaceuticals
- 28 Jun 2011 Status changed from active, no longer recruiting to completed, according to information in an Anacor Pharmaceuticals media release.
- 19 Apr 2011 Results will be presented at the 2011 Society for Investigative Dermatology (SID) Annual Meeting, according to a Anacor media release.
- 15 Mar 2011 Final results are expected in mid-2011, according to an Anacor Pharmaceuticals media release,